Skip to content
Review Open access

Characteristics of adverse events following immunization reporting systems: A scoping review

Jul 2026 · Health Informatics Journal · Vol 32 · 0 citations · 96 references
Computer Science Medicine

TL;DR

Characteristics of adverse events following immunization (AEFI) reporting systems and vaccine adverse events reporting systems (VAERS) including technical platforms, user groups, data elements, functional and non-functional requirements are presented.

Abstract

Objective This study aimed to identify characteristics of adverse events following immunization (AEFI) reporting systems and vaccine adverse events reporting systems (VAERS) including technical platforms, user groups, data elements, functional and non-functional requirements. Methods In this scoping review, various databases were searched from 1st January 2015 to 31st December 2024, and all types of studies that explained AEFI reporting system/VAERS characteristics were considered. The findings were reported descriptively. Results Different technical platforms including web-based, mobile-based, or hybrid platforms were used by multiple user groups. Data elements included personal, clinical, vaccination, and adverse events data. The functional requirements included recording vaccination and adverse events data as well as generating reports. Non-functional requirements were related to system security, data privacy, etc. Conclusion This review presented a set of characteristics that has been considered for different AEFI reporting systems and VAERS. The results can be used for designing more comprehensive AEFI reporting systems in different countries. These features along with new digital technologies and analytical tools including artificial intelligence offer more potential to enhance efficiency and effectiveness. Future research should focus on AI-driven methodologies, including natural language processing, machine learning techniques, and predictive analytics, while addressing ethical, regulatory, and practical challenges.

Read PDF

Similar papers

Open access Sep 2026

Serious and Non-serious Hepatitis Reports in the U.S. Vaccine Adverse Event Reporting System, 1990–2026: A Cross-Sectional Analysis

Background Post-marketing surveillance monitors reports of adverse events following vaccination, including reports of hepatitis. The Vaccine Adverse Event Reporting System (VAERS) is a passive surveillance system that can describe reporting patterns but cannot establish incidence, risk, or causality. This study aimed t...

Paula Aragón Gutierrez, Deepti Botlaguduru, Asritha Chowdary Medarametla et al. · 0 citations
Open access Aug 2026

Assessment of Adverse Events Following Immunization Surveillance System in Terms of Documentation and Reporting Mechanisms

Case reporting form, preliminary case investigation form, and final case investigation form of all cases that occurred from January 2017 to June 2018 were obtained from the concerned authorities and the data obtained was compiled and analyzed using Microsoft Excel 2013.

S. Simon, Rohan Sangam, Shalini Rawat et al. · 0 citations
Review Open access Oct 2026

Adverse Events Following Immunization: Mechanisms, Clinical Manifestations, Surveillance, and Public Health Management-A Narrative Review

Abstract Immunization is a cornerstone of global public health, preventing substantial morbidity and mortality worldwide. However, the long-term success of immunization programs depends not only on vaccine effectiveness but also on robust systems for monitoring and managing vaccine safety. Adverse Events Following Immu...

Tambwe Patrick, Omari Basombelwa John, Bigabwa Baharanyi Dominique et al. · 0 citations
Open access Aug 2026

ANALYSIS OF SPONTANEOUS ADVERSE DRUG REACTION REPORTS AND APPROACHES TO PHARMACOVIGILANCE QUALITY ASSESSMENT IN THE REPUBLIC OF KAZAKHSTAN IN 2025

Introduction: Spontaneous reports are a key source for detecting medicine safety signals. However, absolute report counts do not represent the population incidence of adverse reactions and cannot be used to directly compare the safety of individual medicines. Assessing report structure and data completeness is therefor...

N. Nagiyeva, G. Kadyrbayeva, A. Zhurynova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.